Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation

ISME Journal

Volumn 11, Issue 8, 2017, Pages 1877-1889

  Fuentes, Susana ^a   Rossen, Noortje G ^b   Van Der Spek, Mirjam J ^b   Hartman, Jorn H A ^a   Huuskonen, Laura ^c   Korpela, Katri ^c   Salojärvi, Jarkko ^c   Aalvink, Steven ^a   De Vos, Willem M ^a,c   D'Haens, Geert R ^b   Zoetendal, Erwin G ^a   Ponsioen, Cyriel Y ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM; DISEASE INCIDENCE; GENETIC ANALYSIS; MICROBIAL ACTIVITY; MICROBIAL ECOLOGY;

BACTERIA (MICROORGANISMS); BACTEROIDETES; CLOSTRIDIUM; PROTEOBACTERIA; RUMINOCOCCUS GNAVUS;

ADULT; BACTERIUM; CHRONIC DISEASE; CONTROLLED STUDY; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; GENETICS; HUMAN; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYLOGENY; RANDOMIZED CONTROLLED TRIAL; ULCERATIVE COLITIS;

ADULT; BACTERIA; CHRONIC DISEASE; COLITIS, ULCERATIVE; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; PHYLOGENY;

EID: 85017473671     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2017.44     Document Type: Article

References (52)

1. Angelberger S, Lichtenberger C, Gratzer C, Papay P, Primas C, Eser A et al. (2012). P374 Fecal transplantation in patients with moderately to severely chronic active ulcerative colitis (UC). J Crohn's Colitis 6: S159-S159.
2. Aroniadis OC, Brandt LJ, Greenberg A, Borody T, Kelly CR, Mellow M et al. (2016). Long-term follow-up study of fecal microbiota transplantation for severe and/or complicated Clostridium difficile infection: a multicenter experience. J Clin Gastroenterol 50: 398-402.
3. Basset C, Holton J, Bazeos A, Vaira D, Bloom S. (2004). Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease Dig Dis Sci 49: 1425-1432.
4. Benjamini Y, Hochberg Y. (1995). Controlling the false discovery rate-a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57: 289-300.
5. Berry D, Reinisch W. (2013). Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases Best Pract Res Clin Gastroenterol 27: 47-58.
6. Boesmans L, Ramakers M, Arijs I, Windey K, Vanhove W, Schuit F et al. (2015). Inflammation-induced downregulation of butyrate uptake and oxidation is not caused by a reduced gene expression. J Cell Physiol 230: 418-426.
7. Borody T, Wettstein A, Campbell J, Leis S, Torres M, Finlayson S et al. (2012). Fecal microbiota transplantation in ulcerative colitis: review of 24 years experience. Am J Gastroenterol 107: S665-S665.
8. Claesson MJ, O'Sullivan O, Wang Q, Nikkila J, Marchesi JR, Smidt H et al. (2009). Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One 4: e6669.
9. De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S et al. (2015). Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 64: 447-458.
10. Dicksved J, Halfvarson J, Rosenquist M, Jarnerot G, Tysk C, Apajalahti J et al. (2008). Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2: 716-727.
11. Eeckhaut V, Machiels K, Perrier C, Romero C, Maes S, Flahou B et al. (2013). Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62: 1745-1752.
12. Frank DN St, Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104: 13780-13785.
13. Huda-Faujan N, Abdulamir AS, Fatimah AB, Anas OM, Shuhaimi M, Yazid AM et al. (2010). The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4: 53-58.
14. Iraporda C, Errea A, Romanin DE, Cayet D, Pereyra E, Pignataro O et al. (2015). Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology 220: 1161-1169.
15. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P et al. (2011). Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60: 631-637.
16. Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. (2003). Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol 38: 164-171.
17. Kang S, Denman SE, Morrison M, Yu Z, Dore J, Leclerc M et al. (2010). Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis 16: 2034-2042.
18. Kaser A, Zeissig S, Blumberg RS. (2010). Inflammatory bowel disease. Annu Rev Immunol 28: 573-621.
19. Kostic AD, Xavier RJ, Gevers D. (2014). The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146: 1489-1499.
20. Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM et al. (2013). Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 19: 2155-2165.
21. Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H Jr et al. (2013). Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 56: 597-601.
22. Lahti L, Salojarvi J, Salonen A, Scheffer M, de Vos WM. (2014). Tipping elements in the human intestinal ecosystem. Nat Commun 5: 4344.
23. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA et al. (2013). Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31: 814-821.
24. Louis P, Flint HJ. (2007). Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol 73: 2009-2012.
25. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V et al. (2014). A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63: 1275-1283.
26. Maharshak N, Huh EY, Paiboonrungruang C, Shanahan M, Thurlow L, Herzog J et al. (2015). Enterococcus faecalis gelatinase mediates intestinal permeability via protease-activated receptor 2. Infect Immun 83: 2762-2770.
27. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F et al. (2007). Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 6: 546-551.
28. McDonald D, Clemente JC, Kuczynski J, Rideout JR, Stombaugh J, Wendel D et al. (2012). The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. Gigascience 1: 7.
29. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C et al. (2015). Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149: 102-109 e106.
30. Nadkarni MA, Martin FE, Jacques NA, Hunter N. (2002). Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266.
31. Nagalingam NA, Lynch SV. (2012). Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 18: 968-984.
32. Ohkusa T, Yoshida T, Sato N, Watanabe S, Tajiri H, Okayasu I. (2009). Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol 58: 535-545.
33. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR et al. (2004). Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
34. Paramsothy S, Kamm M, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D et al. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389: 1218-1228.
35. Petersen AM, Halkjaer SI, Gluud LL. (2015). Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol 50: 1-9.
36. Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI et al. (2010). Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105: 2420-2428.
37. Rajilic-Stojanovic M, Heilig HG, Molenaar D, Kajander K, Surakka A, Smidt H et al. (2009). Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11: 1736-1751.
38. Rajilic-Stojanovic M, Shanahan F, Guarner F, de Vos WM. (2013). Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 19: 481-488.
39. Rajili-Stojanovi M, Heilig HGHJ, Tims S, Zoetendal EG, de Vos WM. (2013). Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 15: 1146-1159.
40. Rangel I, Sundin J, Fuentes S, Repsilber D, de Vos WM, Brummer RJ. (2015). The relationship between faecalassociated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther 42: 1211-1221.
41. Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A et al. (2015). Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149: 110-118 e114.
42. Salonen A, Nikkila J, Jalanka-Tuovinen J, Immonen O, Rajilic-Stojanovic M, Kekkonen RA et al. (2010). Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods 81: 127-134.
43. Sartor RB. (2006). Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3: 390-407.
44. Stams AJ, Van Dijk JB, Dijkema C, Plugge CM. (1993). Growth of syntrophic propionate-oxidizing bacteria with fumarate in the absence of methanogenic bacteria. Appl Environ Microbiol 59: 1114-1119.
45. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. (2014). The role of short-chain fatty acids in health and disease. Adv Immunol 121: 91-119.
46. ter Braak CJF, Šmilauer P. (2012). Canoco Reference Manual and User's Guide: Software For Ordination, Version 5. 0. Microcomputer Power: Ithaca, NY, USA.
47. van den Bogert B, de Vos WM, Zoetendal EG, Kleerebezem M. (2011). Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 77: 2071-2080.
48. Vermeiren J, Van den Abbeele P, Laukens D, Vigsnaes LK, De Vos M, Boon N et al. (2012). Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment. FEMS Microbiol Ecol 79: 685-696.
49. Vernia P, Annese V, Bresci G, d'Albasio G, D'Inca R, Giaccari S et al. (2003). Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 33: 244-248.
50. Wexler HM. (2007). Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 20: 593-621.
51. Winter SE, Lopez CA, Baumler AJ. (2013). The dynamics of gut-associated microbial communities during inflammation. EMBO Rep 14: 319-327.
52. Zoetendal EG, Heilig HG, Klaassens ES, Booijink CC, Kleerebezem M, Smidt H et al. (2006). Isolation of DNA from bacterial samples of the human gastrointestinal tract. Nat Protocols 1: 870-873.